Astellas Pharma (OTCMKTS:ALPMY – Get Free Report) posted its quarterly earnings results on Wednesday. Astellas Pharma had a net margin of 13.66% and a return on equity of 23.54%. Astellas Pharma Stock Up 2.2%OTCMKTS ALPMY traded up $0.30 on Wednesday, reaching $14.11. Get Astellas Pharma alerts:Analyst Ratings ChangesSeparately, Zacks Research downgraded shares of Astellas Pharma from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Featured StoriesReceive News & Ratings for Astellas Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astellas Pharma and related companies with MarketBeat.com's FREE daily email newsletter.